ASHLAND, Ohio--(BUSINESS WIRE)--WIL Research Laboratories, LLC and WIL Research Holding Company, Inc. are pleased to announce the acquisition of Midwest BioResearch, LLC.
Together, Midwest BioResearch and WIL Research shall integrate their service offerings through scientific collaboration, sharing of best practices and marketing to provide a seamless bridge between these two highly regarded scientific organizations. Midwest BioResearch’s significant expertise in immunoanalytical and bioassay techniques and small molecule bioanalysis, supporting both clinical and nonclinical research, and their expertise in genetic toxicology, complements WIL Research’s contract research service offerings that include expertise in chronic, neuro-, inhalation, and intravenous toxicology, developmental and reproductive toxicology, safety pharmacology, bioanalytical chemistry and metabolism.
This acquisition ensures the continuity of management, quality science and service to our clients. Michael Schlosser, PhD, DABT, President and Founder of Midwest BioResearch, will continue to lead the existing Skokie, Illinois site reporting to Christopher P. Chengelis, PhD, DABT, Vice President and Chief Scientific Officer at WIL Research. Dr. Schlosser has more than 20 years of experience within the pharmaceutical industry and 25 years of experience in toxicology. “Midwest BioResearch rounds out our service offerings, particularly in the areas of genetic toxicity and biotech and clinical support capabilities,” said Dr. Chengelis. “We also benefit from a world-class staff with significant pharmaceutical and biotechnology industry experience and the addition of a program services consulting group.”
In addition, Sal Guccione, Chief Executive Officer at WIL Research Holding Company, Inc. stated “that this transaction greatly enhances our capabilities to serve our clients in small and large molecule drug development. We are delighted to welcome this experienced team to the WIL family of research companies.”
Note for the Editor:
Midwest BioResearch, LLC was founded in 2003 by scientists, directors and managers from major pharmaceutical companies to provide drug disposition and toxicology services. The company provides significant experience in protein and small molecule bioanalysis, genetic toxicology and structure identification, along with nonclinical safety assessment and program services, supporting both discovery and development within the pharmaceutical industry.
The company occupies a 16,000 square foot facility in Skokie, Illinois at the Illinois Science + Technology Park, the location of a former Pharmacia/Pfizer facility.
For more information please visit www.midwestbioresearch.com
WIL Research Laboratories, LLC is a contract research organization that provides an interdisciplinary approach to non-clinical toxicology, pharmacology, metabolism and both clinical and non-clinical bioanalytical services. The company provides product safety assessment research and services to the pharmaceutical, biotechnology, chemical (agricultural and industrial), food additive, and veterinary medicine industries. Founded in 1976, it is located on a 78-acre campus in Ashland, Ohio with a growing base of over 700 employees. Among its many scientific services, WIL Research is considered by most experts in the industry to be the worldwide leader in developmental and reproductive toxicology. It was acquired by WIL Research Holding Company, Inc. in a management buyout in September 2004 as the platform organization for a global safety assessment and product development scientific outsourcing service group.
For more information please visit www.wilresearch.com
WIL Research Holding Company, Inc. is a privately held global organization that provides product safety toxicological research, bioanalytical, and formulation services. WIL Research Holding Company was created to address global client needs and assist clients in accelerating product development by offering a range of services through a family of Contract Research Organizations, each with a strong reputation in the scientific community for consistently delivering the highest scientific and technical quality, expertise, flexibility and client attentiveness.
The realization of WIL Research Holding Company’s vision began with the acquisition of WIL Research Laboratories in 2004. Today, with the addition of Midwest BioResearch, WIL Research Holding Company consists of five companies with approximately 1,100 dedicated scientific, technical and support personnel with locations in the United States, Europe and Japan.
For more information please visit www.wilholding.com